Cargando…
A polymorphism in the CYP17 gene is associated with male breast cancer
The CYP17 gene codes for the cytochrome P450c17α enzyme that is involved in the synthesis of oestrogens. This case-control study from the South East of Scotland shows that a polymorphism of the CYP17 gene is associated with an increased risk of male breast cancer. © 1999 Cancer Research Campaign
Autores principales: | Young, I E, Kurian, K M, Annink, C, Kunkler, I H, Anderson, V A, Cohen, B B, Hooper, M L, Wyllie, A H, Steel, C M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374358/ https://www.ncbi.nlm.nih.gov/pubmed/10487625 http://dx.doi.org/10.1038/sj.bjc.6690663 |
Ejemplares similares
-
A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancer
por: Young, I E, et al.
Publicado: (2000) -
Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk
por: Rizzolo, Piera, et al.
Publicado: (2019) -
CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status
por: Gudmundsdottir, K, et al.
Publicado: (2003) -
No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.
por: Dunning, A. M., et al.
Publicado: (1998) -
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors
por: Ambrosone, Christine B, et al.
Publicado: (2003)